RadioSensitivity Atlas: Bone Marrow Cell Radio-Response Database & Dosimetry Service
A specialized clinical laboratory service that performs ex vivo radiation sensitivity testing on patient bone marrow samples pre-treatment, measuring clonogenic survival curves and DNA damage kinetics across HSC, progenitor, and stromal populations. Oncologists receive a patient-specific radio-sensitivity profile (within 5 days) with recommended dose modifications and timing protocols to preserve marrow function while maintaining tumor control. The service combines automated high-throughput colony assays, flow cytometry sorting, and machine learning models trained on 500+ patient outcomes to predict which marrow niches tolerate specific dose/fractionation schedules.
25 weeks • 70% confidence
Value Proposition
Eliminates guesswork in marrow protection by providing actual patient cell data rather than population averages; allows dose escalation in radio-resistant patients (improving cure rates) and de-escalation in sensitive patients (preventing aplastic anemia); reduces hospitalization for transfusions/G-CSF by 30-40% based on early pilot data
Target Audience
Academic medical centers and large cancer hospitals (300+ bed systems) with active hematologic malignancy and solid tumor programs; radiation oncologists and hematologist-oncologists treating patients with baseline marrow compromise
Key Features
- Same-day bone marrow aspiration processing with flow-sorted HSC/progenitor/stromal fractionation
- Automated clonogenic assay platform measuring survival at 2–8 Gy across 72-hour culture
- Patient-specific dose-response curves delivered with 95% confidence intervals
- And more, with full implementation detail...
Tech Stack
Unlock the full solution
You're seeing a preview. Unlock the complete value proposition, every feature, the full tech stack, the monetization model, and the week-by-week build roadmap, plus a downloadable PDF.
Sign up free to continue3 free solution credits on signup
The build plan is behind the wall
Subscribers get the full monetization model, pricing strategy, and the complete week-by-week roadmap to build this.
Sign up freeOriginal Problem
Predicting and protecting hematopoietic stem cells from radiation damage during cancer treatmentOncologists and radiologists struggle to protect bone marrow stem cells from radiation toxicity during cancer therapy, leading to severe complications like aplastic anemia and immunosuppression. Current clinical practice lacks precise methods to identify which cells within bone marrow niches are most vulnerable, forcing doctors to use conservative dosing that reduces treatment efficacy. Researchers need better understanding of radio-sensitivity variations in different bone marrow cell populations to optimize radiation protocols without sacrificing therapeutic outcomes.
Score: 17.5%